tiprankstipranks
Advertisement
Advertisement
Zai Lab receives FDA Fast Track Designation for zocilurtatug pelitecan
PremiumThe FlyZai Lab receives FDA Fast Track Designation for zocilurtatug pelitecan
2M ago
Zai Lab price target lowered to $44 from $47 at Citi
Premium
The Fly
Zai Lab price target lowered to $44 from $47 at Citi
2M ago
Zai Lab reports Q1 EPS (4c), consensus (53c)
Premium
The Fly
Zai Lab reports Q1 EPS (4c), consensus (53c)
3M ago
Zai Lab Advances DLLEVATE Trial In Relapsed Small Cell Lung Cancer
PremiumCompany AnnouncementsZai Lab Advances DLLEVATE Trial In Relapsed Small Cell Lung Cancer
4M ago
Zai Lab: Validated Povetacicept Data and China IgAN Opportunity Support Upside and Buy Rating
Premium
Ratings
Zai Lab: Validated Povetacicept Data and China IgAN Opportunity Support Upside and Buy Rating
4M ago
Zai Lab Earnings Call: Growth, Pipeline And Volatility
Premium
Company Announcements
Zai Lab Earnings Call: Growth, Pipeline And Volatility
5M ago
Zai Lab Advances New Solid Tumor Drug ZL-1310: What Investors Should Watch
PremiumCompany AnnouncementsZai Lab Advances New Solid Tumor Drug ZL-1310: What Investors Should Watch
5M ago
Zai Lab’s ZL-6201 Study Advances in Sarcoma and Solid Tumors: What Investors Should Watch
Premium
Company Announcements
Zai Lab’s ZL-6201 Study Advances in Sarcoma and Solid Tumors: What Investors Should Watch
5M ago
Zai Lab price target lowered to $39 from $46 at JPMorgan
Premium
The Fly
Zai Lab price target lowered to $39 from $46 at JPMorgan
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100